Neurotoxin-induced cell death in neuronal PC12 cells is mediated by induction of apoptosis

G Walkinshaw1, C M Waters

  • 1Molecular Pharmacology and Toxicology Group, University of Manchester, School of Biological Sciences, U.K.

Neuroscience
|December 1, 1994
PubMed

Insights

Neurotoxin 6-hydroxydopamine induces apoptosis, a programmed cell death, in neuronal cells in vitro. This finding suggests neurotoxins may cause cell death in Parkinson

Area of Science:

  • Neuroscience
  • Cell Biology
  • Toxicology

Background:

  • Neuronal cell death during development occurs via apoptosis, an active, genetically programmed process.
  • Mechanisms of neurotoxin-induced neuronal cell death are poorly understood, contrasting with developmental apoptosis.
  • Necrosis is a passive, uncontrolled cell death pathway, distinct from apoptosis.

Purpose of the Study:

  • To investigate the mechanism of 6-hydroxydopamine-induced neuronal cell death in vitro.
  • To determine if 6-hydroxydopamine triggers apoptosis in neuronal cells.

Main Methods:

  • Utilized the PC12 neuronal cell line for in vitro experiments.
  • Administered 6-hydroxydopamine to induce cell death.
  • Assessed morphological and biochemical hallmarks of apoptosis, including DNA integrity.
  • Used desipramine (monoamine uptake inhibitor) and aurintricarboxylic acid (nuclease inhibitor) to probe the death pathway.

Main Results:

  • 6-Hydroxydopamine induced cell death in PC12 cells with morphological features of apoptosis (cell shrinkage, chromatin condensation, membrane blebbing).
  • Biochemical analysis revealed DNA fragmentation, a hallmark of apoptosis.
  • Apoptosis was suppressed by desipramine and aurintricarboxylic acid, indicating specific intracellular mechanisms and endonuclease involvement.

Conclusions:

  • 6-Hydroxydopamine induces neuronal cell death via apoptosis in vitro.
  • This suggests that environmental or metabolic toxins may trigger apoptosis in neurodegenerative diseases like Parkinson's.
  • Modulating apoptotic pathways could offer therapeutic strategies for neurodegeneration.

Related Concept Videos

Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...